Tech Company Financing Transactions
Moximed Funding Round
Moximed, based in Fremont, secured $91 million from Elevage Medical Technologies, Advent Life Sciences and Cormorant Asset Management.
Transaction Overview
Company Name
Announced On
8/14/2024
Transaction Type
Venture Equity
Amount
$91,000,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the proceeds from the financing to accelerate U.S. commercialization of its MISHA® Knee System, an implantable shock absorber (ISA) for knee osteoarthritis.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
46602 Landing Pkwy.
Fremont, CA 94538
USA
Fremont, CA 94538
USA
Phone
Website
Email Address
Overview
Moximed, Inc. is dedicated to improving the standard of care for patients with osteoarthritis (OA). OA, the most common form of arthritis, leads to a breakdown of the joint's cartilage and often results in joint pain and loss of motion.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anton Clifford
VP - Bus. Development
Keith Fong
VP - Human Resources
Christine Barcelos
VP - Regulatory Affairs
Nancy Isaac
Browse more venture capital transactions:
Prev: 8/13/2024: Profound venture capital transaction
Next: 8/14/2024: Actuate venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs